EFAD ETF Holdings

ETF Components for EFAD - ProShares MSCI EAFE Dividend Growers ETF

Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

Holdings

	Symbol	Grade	Price % Change	Allocation
	DEO	F	0.04	1.46
	NVS	D	0.88	1.37

Represented by ETF Holdings

Keywords: Active Pharmaceutical Ingredients Alcohol Alcoholic Drinks Animal Health Antibiotics Beer Biotechnology Blood Test Canadian Whisky Contact Lens Contact Lenses Diagnostic Products Disposable Product Disposable Products Distilled Drinks Drink Drugs Eye Eye Care Eye Care Products

Industries: Beverages - Wineries & Distilleries Drug Manufacturers - Major

Recent News for ProShares MSCI EAFE Dividend Growers ETF & its Holdings

Date	Stock	Title
Nov 1	NVS	Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY's Q3 Earnings in Focus
Nov 1	DEO	TEQUILA DON JULIO ELEVATES MEXICO'S CULTURAL HERITAGE WITH BREATHTAKING DIA DE MUERTOS GLOBAL CELEBRATIONS
Nov 1	NVS	Madrigal Q3 Earnings Beat, NASH Drug Sales Drive Top Line, Stock Up
Nov 1	NVS	Alnylam Q3 Loss In Line With Estimates, Revenues Miss, Stock Down
Oct 31	DEO	Aged to Perfection: Crown Royal Launches Iconic Reserve Offering with 12-Year Age Statement
Oct 31	NVS	REGN Q3 Earnings and Revenues Beat on Strong Eylea HD & Dupixent Sales
Oct 30	NVS	Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
Oct 30	DEO	Ketel One Family Made Vodka Taps Patrick Schwarzenegger to Serve as First Ever "Spirit Advisor" this Holiday Season
Oct 30	NVS	Lilly's Q3 Earnings Miss, Mounjaro, Zepbound Disappoint, Stock Tanks
Oct 30	NVS	BioMarin Q3 Earnings & Revenues Beat Estimates, '24 Guidance Raised
Oct 30	NVS	ITCI Q3 Loss Wider Than Expected, Revenues Top on Higher Caplyta Sales
Oct 30	NVS	Novartis’ Scemblix gains FDA approval for leukaemia
Oct 30	NVS	Novartis: It's Not Too Late To Buy This Dividend Stock Now
Oct 30	NVS	Novartis Reports Strong Q3 Growth and Raises Guidance
Oct 30	NVS	Novartis AG (NVS) Q3 2024 Earnings Call Highlights: Record Cash Flow and Robust Sales Growth
Oct 29	NVS	Novartis: Strong Financials, But Market Skepticism Persists Amid Pipeline Concerns
Oct 29	NVS	Novartis wins first-line chronic myeloid leukemia indication for Scemblix
Oct 29	NVS	Novartis Scemblix® FDA approved in newly diagnosed CML, offering superior efficacy, and favorable safety and tolerability profile
Oct 29	NVS	Novartis Stock Dives on $800 Million Write-Down
Oct 29	NVS	Novartis Ag (NVS) Q3 2024 Earnings Call Transcript

The investment seeks investment results before fees and expenses that track the performance of the MSCI EAFE Dividend Masters Index. The index targets companies that are currently members of the MSCI EAFE Index ("MSCI EAFE") and have increased dividend payments each year for at least 10 years. It contains a minimum of 40 stocks, which are equally weighted. Under normal circumstances, the fund will invest at least 80% of its total assets in component securities (i.e., securities of the index and comparable securities that have economic characteristics that are substantially identical to the economic characteristics of the securities of the index).
Exchange Traded Fund Dividend MSCI EAFE Msci World

Back to the Main EFAD Page...